chr4-3493242-G-GC
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_173660.5(DOK7):c.1263dupC(p.Ser422LeufsTer97) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,611,824 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_173660.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 10Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- fetal akinesia deformation sequence 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- fetal akinesia deformation sequence 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DOK7 | NM_173660.5 | c.1263dupC | p.Ser422LeufsTer97 | frameshift_variant | Exon 7 of 7 | ENST00000340083.6 | NP_775931.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DOK7 | ENST00000340083.6 | c.1263dupC | p.Ser422LeufsTer97 | frameshift_variant | Exon 7 of 7 | 1 | NM_173660.5 | ENSP00000344432.5 | ||
| DOK7 | ENST00000643608.1 | c.831dupC | p.Ser278LeufsTer258 | frameshift_variant | Exon 5 of 8 | ENSP00000495701.1 | ||||
| DOK7 | ENST00000515886.5 | c.333dupC | p.Ser112LeufsTer97 | frameshift_variant | Exon 4 of 4 | 2 | ENSP00000492194.1 | |||
| DOK7 | ENST00000507039.5 | c.*484dupC | 3_prime_UTR_variant | Exon 7 of 7 | 2 | ENSP00000423614.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152192Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000758 AC: 18AN: 237478 AF XY: 0.0000920 show subpopulations
GnomAD4 exome AF: 0.000123 AC: 179AN: 1459632Hom.: 0 Cov.: 95 AF XY: 0.000116 AC XY: 84AN XY: 726084 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74354 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fetal akinesia deformation sequence 3 Pathogenic:3
Variant confirmed as disease-causing by referring clinical team -
- -
- -
not provided Pathogenic:3
- -
PM2_moderate, PM3_very_strong, PS4 -
Identified with a second DOK7 variant without confirmation of phase in patients with congenital myasthenic syndromes (PMID: 16917026, 37273706, 22661499, 18626973); Frameshift variant predicted to result in protein truncation, as the last 83 amino acids are replaced with 96 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 31589614, 21850686, 18161030, 32153140, 31880392, 33726816, 16917026, 37273706, 22661499, 18626973) -
Congenital myasthenic syndrome 10 Pathogenic:2
- -
- -
Rett syndrome Pathogenic:1
- -
Congenital myasthenic syndrome 10;C4760599:Fetal akinesia deformation sequence 3 Pathogenic:1
- -
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Pathogenic:1
This sequence change results in a frameshift in the DOK7 gene (p.Ser422Leufs*97). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 83 amino acid(s) of the DOK7 protein and extend the protein by 13 additional amino acid residues. This variant is present in population databases (rs751257124, gnomAD 0.02%). This frameshift has been observed in individual(s) with congenital myasthenic syndrome and fetal akinesia deformation sequence (PMID: 16917026, 21850686, 22661499). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1274). For these reasons, this variant has been classified as Pathogenic. -
Fetal akinesia deformation sequence 1 Pathogenic:1
- -
Congenital myasthenic syndrome Pathogenic:1
Variant summary: DOK7 c.1263dupC (p.Ser422LeufsX97) causes a frameshift which results in an extension of the protein. The variant allele was found at a frequency of 7.6e-05 in 237478 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in DOK7 causing Congenital myasthenic syndrome (7.6e-05 vs 0.0014), allowing no conclusion about variant significance. c.1263dupC has been reported in the literature in compound heterozygous and homozygous individuals affected with Congenital myasthenic syndrome (Selcen_2008, Anderson_2008). These data indicate that the variant is very likely to be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
DOK7-related disorder Pathogenic:1
The DOK7 c.1263dupC variant is predicted to result in a frameshift and premature protein termination (p.Ser422Leufs*97). This variant has been reported in individuals with autosomal recessive congenital myasthenic syndrome (Beeson et al. 2006. PubMed ID: 16917026; Anderson et al. 2008. PubMed ID: 18161030; Cossins et al. 2012. PubMed ID: 22661499). It has also been reported in the homozygous state in a case of fetal akinesia deformation sequence (Table 1, Bruno et al. 2011. PubMed ID: 21850686). This variant is reported in 0.017% of alleles in individuals of African descent in gnomAD. Frameshift variants in DOK7 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at